
Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.

Estrogen decline during menopause alters fat, muscle, and lipid metabolism; multimodal lifestyle strategies help reduce cardiovascular risk.

Early intervention during perimenopause can prevent long-term osteoporosis through timely screening and intermittent therapy strategies.

Cynthia Stuenkel, MD, reviews diagnosis, management, and fertility considerations in women with primary ovarian insufficiency.

CBT adapted for menopause shows benefits for vasomotor symptoms, mood, and sleep, according to Danette Conklin, PhD, at The Menopause Society.

Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.

Levonorgestrel IUD offers localized progesterone delivery for endometrial protection during hormone therapy, with minimal systemic effects.

Melissa Mauskar, MD, discusses overlapping vulvar conditions, patient counseling, and the importance of multidisciplinary care

At The Menopause Society Annual Meeting, Caroline Mitchell, MD, MPH, emphasized individualized, evidence-based care and the safety of topical hormones for GSM.

Menopause remains a taboo topic in many cultures, yet women seek to educate themselves and support each other through shared experiences.

Andrew Kaunitz, MD, shares how older women can explore safe contraceptive options while understanding fertility risks.

In a study led by Eugene Declercq, PhD, MBA, infants born to mothers who died during or after pregnancy faced higher mortality rates.

Moe Takenoshita, MBBCh, found that cesarean delivery was linked to a 16% higher risk of developing sleep disorders within a year after childbirth.

Eve Zaritsky, MD, reports that e-visits are a safe, effective, and accessible option for patients seeking oral contraceptives.

Infants born to mothers in rural areas face greater odds of low Apgar scores and limited prenatal care access.

Ethan Lowder, BA, and Alexander Nagrebetsky, MD, MSc, reported that nearly 80% of children fast longer than recommended before surgery.

Carrie B. Hruska, PhD highlights how molecular breast imaging can reveal up to 2.5 times more invasive breast cancers than mammography alone.

Sarah Glynne, MBBS, BSc, and Jayant S. Vaidya, MD, FRCS, PhD, urge clinicians to move beyond blanket bans and support informed, patient-centered care.

Jayant S. Vaidya, MD, FRCS, PhD, and Sarah Glynne, MBBS, BSc, discuss new evidence challenging the blanket ban on HRT use after breast cancer.

New research highlights an increased risk of urinary incontinence following hysterectomy, underscoring the need for long-term management strategies.

As public uncertainty about vaccination during pregnancy grows, experts highlight the vital role of trusted health care providers in addressing hesitancy.

Rising childcare costs, limited access to daycare, and shifting generational attitudes are driving historic declines in US birth rates.

Experts discuss the future of healthcare, emphasizing innovative STI care, education, and the importance of collaboration in improving patient outcomes.

Panelists explore the future of STI screening and management, emphasizing the importance of guidelines and innovative diagnostics in women's health.


Discover how accessible STI testing and early detection enhance maternal-fetal health, reducing risks for mothers and newborns alike.

Innovations in diagnostic testing enhance patient care, empowering women with at-home options and faster access to essential health services.

Experts discuss the FDA's priority review of gepotidacin, an oral gonorrhea treatment, highlighting its potential to improve women's health and access to care.

Experts discuss updates in STI testing, congenital conditions, and best practices for pregnant women in this insightful healthcare panel.

A new analysis shows US births have fallen 22% since 2007, raising concerns about delayed childbearing and shrinking school enrollments.

In the 52-week OASIS-3 trial, elinzanetant significantly reduced the frequency and severity of hot flashes and night sweats.